Public health doesn’t depend on quit-or-nothing

Concerns about youth uptake of vaping, and of long‑term health effects and industry behaviour, are real and must be taken seriously. The evidence base of any health impacts is still evolving, and some findings warrant caution and ongoing regulation.

But one fact is not in dispute: the overwhelming burden of disease from smoking comes from inhaling smoke from burning tobacco – not from nicotine itself. For people who already smoke, switching completely from combustible cigarettes to non‑combustible nicotine products substantially reduces exposure to toxicants.

For the 300,000 New Zealanders who still smoke, this distinction matters. Many won’t quit using willpower or approved cessation methods alone. Denying those people access to less harmful alternatives does not protect health – it prolongs exposure to the most dangerous form of nicotine-delivery products.

Smoking rates have fallen to historic lows – now below 7 percent among adults. Youth smoking has dropped to 1 percent, and the steepest declines have occurred in populations that previously carried the greatest burden, including Māori. These gains coincided with increased uptake of smoke‑free vapes among adults who smoke, alongside regulations to prevent both youth vaping and smoking.

This challenges a persistent assumption: that allowing access to safer alternatives inevitably undermines progress and equity. We’d argue otherwise, that prioritising and allowing for the reduction of harm is saving lives. Refusing to allow for harm reduction (as provided by smoke-free nicotine products), is likely to entrench smoking among those least able to quit.

Success is now framed as achieving nicotine-free status, as if nicotine use itself were the primary harm. Public health progress does not require nicotine abstinence, but if the goal is to reduce death rates and disease, it means reducing exposure to cigarettes as quickly as possible

The lesson from New Zealand is not that harm reduction replaces tobacco control. It’s that combining the two can have a dramatic impact on the health of our population.

As the global community looks for ways to reinvigorate the ‘quit smoking’ message, New Zealand offers real‑world evidence of what becomes possible when policy focuses squarely on outcomes: fewer people smoking, fewer lives lost, and faster gains for those who have historically been left behind.

The tools to accelerate the end of the smoking epidemic already exist. The question is whether we are prepared to use all of them to end smoking. 

Concerns about youth uptake of vaping, and of long‑term health effects and industry behaviour, are real and must be taken seriously. The evidence base of any health impacts is still evolving, and some findings warrant caution and ongoing regulation.

But one fact is not in dispute: the overwhelming burden of disease from smoking comes from inhaling smoke from burning tobacco – not from nicotine itself. For people who already smoke, switching completely from combustible cigarettes to non‑combustible nicotine products substantially reduces exposure to toxicants.

For the 300,000 New Zealanders who still smoke, this distinction matters. Many won’t quit using willpower or approved cessation methods alone. Denying those people access to less harmful alternatives does not protect health – it prolongs exposure to the most dangerous form of nicotine-delivery products.

Smoking rates have fallen to historic lows – now below 7 percent among adults. Youth smoking has dropped to 1 percent, and the steepest declines have occurred in populations that previously carried the greatest burden, including Māori. These gains coincided with increased uptake of smoke‑free vapes among adults who smoke, alongside regulations to prevent both youth vaping and smoking.

This challenges a persistent assumption: that allowing access to safer alternatives inevitably undermines progress and equity. We’d argue otherwise, that prioritising and allowing for the reduction of harm is saving lives. Refusing to allow for harm reduction (as provided by smoke-free nicotine products), is likely to entrench smoking among those least able to quit.

Success is now framed as achieving nicotine-free status, as if nicotine use itself were the primary harm. Public health progress does not require nicotine abstinence, but if the goal is to reduce death rates and disease, it means reducing exposure to cigarettes as quickly as possible

The lesson from New Zealand is not that harm reduction replaces tobacco control. It’s that combining the two can have a dramatic impact on the health of our population.

As the global community looks for ways to reinvigorate the ‘quit smoking’ message, New Zealand offers real‑world evidence of what becomes possible when policy focuses squarely on outcomes: fewer people smoking, fewer lives lost, and faster gains for those who have historically been left behind.

The tools to accelerate the end of the smoking epidemic already exist. The question is whether we are prepared to use all of them to end smoking.